Third Rock Ventures II, L.P.'s Net Worth
$585 Million
Who is Third Rock Ventures II, L.P.?
Third Rock Ventures II, L.P. has an estimated net worth of $585 Million. This is based on reported shares across multiple companies, which include Revolution Medicines, Inc., Jounce Therapeutics, Inc., Blueprint Medicines Corp, Global Blood Therapeutics, Inc., Sage Therapeutics, Inc., MyoKardia Inc, and Allena Pharmaceuticals, Inc..
SEC CIK
Third Rock Ventures II, L.P.'s CIK is 0001488495
Past Insider Trading and Trends
2015 was Third Rock Ventures II, L.P.'s most active year for acquiring shares with 21 total transactions. Third Rock Ventures II, L.P.'s most active month to acquire stocks was the month of October. 2017 was Third Rock Ventures II, L.P.'s most active year for disposing of shares, totalling 25 transactions. Third Rock Ventures II, L.P.'s most active month to dispose stocks was the month of October. 2017 saw Third Rock Ventures II, L.P. paying a total of $3,010,000.00 for 15,528,088 shares, this is the most they've acquired in one year. In 2021 Third Rock Ventures II, L.P. cashed out on 8,411,837 shares for a total of $79,628,830.60, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Revolution Medicines, Inc. (RVMD) Snapshot price: $41.84
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -543.11K |
$30.21 | -$16,406,962.48 |
0
|
Jun 3 - Jun 4
| |||
Form 4
| -71.55% | -1.37M |
$30.57 | -$41,764,208.12 | 543.11K |
May 25 - May 26
| |||
Form 4
| +2,560.14% | 10.52M |
—
|
—
| 10.93M |
Feb 18
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jounce Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -39.35% | -1.75M |
—
|
—
| 2.7M |
Scheduled
|
Sep 15
| ||
Form 4
| -25.22% | -1.50M |
—
|
—
| 4.45M |
Scheduled
|
Jun 10
| ||
Form 4
| -8.50% | -552.52K |
$8.00 | -$4,420,160.00 | 5.95M |
May 25
| |||
Form 4
| -16.13% | -1.25M |
—
|
—
| 6.5M |
Scheduled
|
Mar 11
| ||
Form 4
| -15.76% | -1.45M |
$11.75 | -$17,037,500.00 | 7.75M |
Mar 1
| |||
Form 4
| -0.16% | -15.00K |
$7.01 | -$105,075.00 | 9.2M |
Nov 19
| |||
Form 4
| -0.16% | -15.00K |
$7.25 | -$108,772.50 | 9.22M |
Nov 17
| |||
Form 4
| -9.77% | -1.00M |
—
|
—
| 9.23M |
Nov 11
| |||
Form 4
| +2,350.00% | 12.74M |
—
|
—
| 13.28M |
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Blueprint Medicines Corp (BPMC) Snapshot price: $86.43
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -22.45% | -1.00M |
—
|
—
| 3.45M |
Scheduled
|
Feb 27
| ||
Form 4
| -18.34% | -1.00M |
$35.28 | -$35,275,000.00 | 4.45M |
Feb 7
| |||
Form 4
| -18.03% | -1.20M |
—
|
—
| 5.45M |
Apr 14
| |||
Form 4
| -8.37% | -618.44K |
—
|
—
| 6.77M |
Nov 18
| |||
Form 4
| +2,610.79% | 7.12M |
—
|
—
| 7.39M |
May 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Global Blood Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -28.78% | -1.00M |
—
|
—
| 2.48M |
Scheduled
|
Jun 14
| ||
Form 4
| -22.42% | -1.05M |
—
|
—
| 3.64M |
Scheduled
|
Apr 11 - May 17
| ||
Form 4
| -30.89% | -2.00M |
—
|
—
| 4.48M |
Scheduled
|
Apr 6
| ||
Form 4
| -22.85% | -2.05M |
$26.17 | -$52,245,475.97 | 6.91M |
Mar 2
| |||
Form 4
| -21.11% | -2.00M |
—
|
—
| 7.48M |
Scheduled
|
Dec 14
| ||
Form 4
| -15.67% | -2.00M |
$19.36 | -$38,720,000.00 | 10.76M |
Nov 14
| |||
Form 4
| -16.03% | -2.00M |
—
|
—
| 10.48M |
Nov 3
| |||
Form 4
| +2,083.16% | 11.9M |
—
|
—
| 12.48M |
Aug 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Sage Therapeutics, Inc. (SAGE) Snapshot price: $7.5
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -25.69% | -1.00M |
—
|
—
| 2.89M |
Aug 19
| |||
Form 4
| -17.92% | -850.00K |
$31.25 | -$26,562,500.00 | 3.89M |
May 16
| |||
Form 4
| -25.50% | -1.67M |
—
|
—
| 4.87M |
Nov 12
| |||
Form 4
| -25.90% | -2.29M |
—
|
—
| 6.54M |
Aug 18
| |||
Form 4
| -10.00% | -981.20K |
—
|
—
| 8.83M |
Jun 19
| |||
Form 4
| -11.38% | -1.26M |
—
|
—
| 9.77M |
Jan 27
| |||
Form 4
| -5.59% | -652.76K |
—
|
—
| 11.03M |
Jan 16
| |||
Form 4
| +2,353.02% | 11.2M |
—
|
—
| 11.68M |
Jul 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||